Mulya.ai
Ticker
CAH
Scenario
Key Inputs
Revenue est.?Analyst
OP margin est.?hist_ind
Reinvestment est.?projected
R&D capitalizedNo
Leases factoredNo
Key Assumptions
WACC ?6.9%
ERP ?4.5%
Risk-free rate ?4.1%
Beta (blended) ?0.616
Beta (levered) ?0.697
Terminal OM% ?0.9%
Segment conc. ?92% dominant
Terminal growth ?4.1%
Bond rating ?AA · 0.90%
ROIC option ?Opt 4 · 23.5%
Prob of failure ?0.0%
Pipeline validated · 2026-05-17

CAH · Cardinal Health, Inc.

$214.052026-05-17
Sector: Healthcare; Industry: Medical - Distribution; Sub-Industry: Health Care Distributors

Intrinsic Value Range Comparison · Mulya.ai

Bull
$191
-10.7% vs market
Base · active
$177
-17.4% vs market
Bear
$103
-52.1% vs market
Mulya.ai vs Analyst IV Comparison?
Bear $103
Base $177
Bull $191
Market $214
Median $256
Market Price $214
Mulya.ai Base $177
Analysts Median $256
Mulya.ai IV range ($103 · $191)
Analysts Range ($220 · $275)
Fundamentals · historical + forward · base
italics = DCF projection
PeriodRevenueRev Gr ?Ops M% ?Tax Rate ?NOPAT ?
Reinvest ?
FCFF ?WACC% ?PV FCFF ?ROIC ?Inv. Cap ?EPS ?P/E
2022.Q2$162.5B0.3%45.0%$260MM−$1.4B−$1.2B4.4%7.5%$3.5B$2.58
2023.Q2$181.3B11.6%-0.3%0.0%−$4.0B$3.1B−$904MM9.5%-279.7%−$605MM$-3.96
2024.Q2$205.0B13.0%0.4%43.6%$424MM$1.7B$2.1B6.4%0.0%−$3.3B$1.39
2025.Q2$226.8B10.7%0.5%26.6%$912MM−$4.2B−$3.3B7.4%0.0%$805MM$3.59
2026.Q2$244.5B7.8%1.0%26.4%$1.9B−$3.0B−$1.1B6.9%85.6%$3.5B$7.0320.0
italics below = DCF projection · 10yr Rev CAGR: 8.8%
2027.Q2$272.1B+11.3%1.0%25.8%$2.1B−$2.4B−$318MM7.0%−$297MM44.0%$6.0B$8.8324.2
2028.Q2$294.7B+8.3%1.0%25.1%$2.2B−$1.6B$662MM7.2%$577MM33.2%$7.5B$9.4722.6
2029.Q2$321.6B+9.1%1.0%24.5%$2.4B−$1.6B$843MM7.3%$685MM29.1%$9.1B$10.2220.9
2030.Q2$357.5B+11.2%1.0%23.8%$2.7B−$1.8B$851MM7.5%$643MM26.6%$10.9B$11.2419.0
2031.Q2$400.2B+11.9%0.9%23.2%$2.9B−$1.9B$1.0B7.7%$703MM24.3%$12.8B$12.1917.6
Term. Yr+$590.2B4.1%0.9%20.0%$4.4B−$774MM$3.7B8.6%$38.6B23.5%
Active scenario IV: $177 (-17.4% vs market)